References
- van Ditzhuijsen T J M, de Witte-van der Schoot E, van Loon A M, Rijntjes P J M, Yap S H. Hepatitis B virus infection in an institution for the mentally retarded. Am J Epidemiol 1988; 128: 629–638
- Hollinger F B, Goyal R K, Hersh T, Powell H C, Schulman R J, Melnick J L. Immune response to hepatitis virus type B in Down's syndrome and other mentally retarded patients. Am J Epidemiol 1972; 95: 356–362
- Lochitch G, Singh V K, Puterman M L, Godolphin W J, Sheps S, Tingle A J, Wong F, Quigley G. Age-related changes in humoral and cell-mediated immunity in Down syndrome children living at home. Pediatr Res 1987; 22: 536–540
- Avanzini M A, Söderström T, Wahl M, Burgio G R, Hanson LÅ. IgG subclass deficiency in patients with Down's syndrome and aberrant hepatitis B vaccine response. Scand J Immunol 1988; 28: 456–470
- Bryan J P, Sjogren M H, Perine P L. Low-dose intradermal and intramuscular vaccination against hepatitis B. Clin Infect Dis 1992; 14: 697–707
- Struve J, Aronsson B, Frenning B, Granath F, von Sydow M, Weiland O. Intramuscular versus intradermal administration of a recombinant hepatitis B vaccine: A comparison of response rates and analysis of factors influencing the antibody response. Scand J Infect Dis 1992; 24: 423–429
- Wahl M, Hermodsson S, Iwarson S. Immune response to hepatitis B vaccination in the mentally retarded. Scand J Infect Dis, Suppl 1983; 38: 24–27
- Heijtink R A, Jong D P, Schalm S W, Masurel N. Hepatitis B vaccination in Down's syndrome and other mentally retarded patients. Hepatology 1984; 4: 611–614
- Troisi C L, Heiberg D A, Hollinger B F. Normal immune response to hepatitis B vaccine in patients with Down's syndrome. JAMA 1985; 254: 3196–3199
- van Damme P, Vranckx R, Meheus A. Immunogenicity of a recombinant DNA hepatitis B vaccine in institutionalized patients with Down's syndrome. Vaccine 1990; 8: 53–55, Suppl
- Vajro P, Lettera P, Fontanella A, Sbregllia C, Manzillo E, Sartorio R, Del Giudice E. Vaccination against hepatitis B in preschool children with Down's syndrome. J Intellect Disabil Res 1992; 36: 77–81
- Hayashi J, Kashiwagi S, Noguchi A, Nakashima K, Ikematsu H, Kajiyama W. Intradermal hepatitis B vaccination for mentally retarded patients. J Infect 1989; 19: 119–125
- Hayashi J, Nakashima K, Noguchi A, Morofuji M, Kashiwagi S. Cost effectiveness of intradermal vs. subcutaneous hepatitis B vaccination for the mentally handicapped. J Infect 1991; 23: 39–45
- Heijting R A, Breukers A A F M, den Hartigh G, Schepman R W M, Schmitz P I M, Schalm S W, Masurel M. Low dose intradermal vaccination against hepatitis B in mentally retarded patients. Vaccine 1988; 6: 59–61
- de Graeff P A, Danker J, de Zeeuw D, Gips C H, van der Hem G K. Immune response to two different hepatitis B vaccines in haemodialysis patients: a 2-year follow up. Nephron 1985; 40: 155–160
- Kurtz J B, Alder M J, Mayon-White R T, Juel-Jensen B E, Rodgers T M, Babic G M. Plasma-derived versus recombinant hepatitis B vaccines. Lancet 1989; 2: 451